BioSpace News Archive

Drug Development

Cerus Reports Positive Top-Line Results from Chronic Anemia Phase 3 Study Evaluating INTERCEPT Red Blood Cells in Thalassemia Patients

The results from the SPARC study provide important clinical data regarding the safety profile of INTERCEPT-treated RBCs in a chronically transfused patient population and support Cerus’ INTERCEPT RBC CE mark submission, which is planned for the second half of 2018.

January 23, 2018
·
7 min read
Business

Gilead Sciences to Release Fourth Quarter and Full Year 2017 Financial Results on Tuesday, February 6, 2018

Gilead Sciences, Inc. announced today that its fourth quarter and full year 2017 financial results will be released on Tuesday, February 6, after the market closes.

January 23, 2018
·
1 min read
Pharm Country

Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock

Rocket also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering.

January 23, 2018
·
5 min read
Genetown

Synlogic Announces Proposed Public Offering of Common Stock

Synlogic intends to grant the underwriters a 30-day option to purchase up to an aggregate of an additional 15% of the shares of its common stock offered in the public offering.

January 23, 2018
·
5 min read
Pharm Country

PAVmed Announces Closing of Firm Commitment Common Stock Offering

PAVmed announced underwritten public offering of 2,415,278 shares of its common stock at a public offering price of $1.80 per share.

January 23, 2018
·
4 min read
Biotech Beach

Aerie Pharmaceuticals Announces Public Offering of Common Stock

Aerie today announced that it has commenced a registered underwritten public offering of $75 million of shares of its common stock.

January 23, 2018
·
3 min read
Genetown

Ultivue Inc. Announces Completion of its Series B Financing

Ultivue Inc. announced today that it has closed a $20 million Series B funding round led by existing investor ARCH Venture Partners.

January 23, 2018
·
2 min read
Business

Nuevolution Appoint Dr. Paul Scigalla as Chief Medical Officer on Consultancy Basis

Dr. Scigalla, is a physician and medical researcher with more than 30 years of experience in clinical development across multiple therapeutic areas.

January 23, 2018
·
2 min read
MRIGlobal Immunologist Collaborates With UCLA in Published Study Showing Ebola Survivors May Have Lifetime Immunity

Research from a UCLA Fielding School of Public Health study with collaboration from MRIGlobal concludes that survivors of the first known Ebola outbreak may be key to the development of vaccines and therapeutic drugs to treat future outbreaks.

January 23, 2018
·
3 min read
Business

J&J Reports 2017 Fourth-Quarter Results

Johnson & Johnson today announced sales of $20.2B for the fourth quarter of 2017, an increase of 11.5% as compared to the fourth quarter of 2016.

January 23, 2018
·
37 min read